Buy, hold, sell: Evolution Mining, Netwealth, and Nufarm shares

What is Morgans saying about these popular shares? Let's dig deeper into things.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Looking for some new portfolio additions? If you are, it could be worth hearing what Morgans is saying about the three popular ASX shares listed below.

Does the broker rate them as buys, holds, or sells? Let's find out:

A man sits in deep thought with a pen held to his lips as he ponders his computer screen with a laptop open next to him on his desk in a home office environment.

Image source: Getty Images

Evolution Mining Ltd (ASX: EVN)

This gold miner delivered a solid quarterly update this week despite battling bad weather and maintenance impacts.

In response, Morgans has upgraded Evolution Mining's shares to an accumulate rating with a $16.10 price target. Commenting on the company, the broker said:

Gold production met expectations despite weather and maintenance impacts, with weaker copper and higher AISC driven by Ernest Henry disruptions. Strong 4Q26 expected to achieve FY26 guidance. Achieves net cash position with an updated capital management policy expected at its FY26 result in August. We upgrade to an ACCUMULATE (from HOLD) following recent weakness across the gold sector which we believe has uncovered value in a high-quality name, despite a strong share price reaction post the result.

Netwealth Group Ltd (ASX: NWL)

Another ASX share that Morgans has been looking at is Netwealth. In response to the investment platform provider's quarterly update, the broker has retained its accumulate rating with a $29.00 price target.

The broker notes that although Netwealth's fund under administration (FUA) fell short of expectations, this was due to market weakness. And with the market rebounding this month, it believes its FUA will have improved in the fourth quarter. It explains:

NWL's 3Q26 net-flows of $3.96bn came in modestly ahead of expectations, however market volatility during the period eroded this solid performance to see 3Q26 FUA ending the quarter flat QoQ at A$125.8bn, (vs. Consensus A$129.8bn). Despite ongoing volatility and uncertainty tied to a US/Middle East conflict and a potential resolution, market momentum has recovered from peak pessimism in the March Quarter, with the ASX All Ordinaries +5.6% month-to-date in April'26, which will have seen FUA growth momentum improve post quarter end.

Looking through this near-term volatility NWL remains on track [to] deliver solid growth FY26F and well placed to capitalise on the long runway of opportunity ahead. We retain our ACCUMULATE rating, with a Price target of $29.00/sh.

Nufarm Ltd (ASX: NUF)

Finally, Morgans was pleased with this agricultural chemicals company's guidance for the first half of FY 2026. It notes that its earnings are slightly ahead of expectations and its balance sheet deleveraging is far better than expected.

As a result, it has reaffirmed its buy rating with a $4.05 price target. It said:

Pleasingly, NUF's 1H26 EBITDA guidance was slightly higher than expected and it has had a strong 1H. Importantly, its leverage guidance is materially better than expected. Initial outlook comments for the 2H26 were positive and a new A$50m cost out program has been announced.

Given the appreciation in active ingredient and fish oil prices, NUF's previous FY26 guidance could prove to be conservative. NUF is our key pick of the ag and chemical sector. The company is materially undervalued and we reiterate our BUY rating with a new price target of A$4.05.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Netwealth Group. The Motley Fool Australia has positions in and has recommended Netwealth Group. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Broker Notes

A graphic image of a pile of gold coins balanced precariously with a house on top with smoke coming out of the chimney and a human figure with hands up as if to shield himself from the prospect of the house falling.
Broker Notes

This debt collector could surge 47% on negative gearing changes, Shaw and Partners says

A weaker housing market could be a boon for this company.

Read more »

Three young nerds dressed in suits with thinking caps and lightbulbs
Broker Notes

Brokers name 3 ASX shares to buy right now

Let's find out which shares top brokers are feeling bullish about this week.

Read more »

A woman in a red dress holding up a red graph.
Broker Notes

4 ASX shares Macquarie says could return more than 40%

The broker has made some bold predictions.

Read more »

A woman leans forward with her hand behind her ear, as if trying to hear information.
Broker Notes

Down 60%, are Cochlear shares now a bargain buy?

A leading analyst provides his outlook for Cochlear’s beaten-down shares.

Read more »

A businessman hugs his computer and smiles.
Broker Notes

Why this ASX stock is a 'compelling value play'

Value investors might want to check out this share that Bell Potter is bullish on.

Read more »

Man holding a calculator with Australian dollar notes, symbolising dividends.
Broker Notes

Should I buy Rio Tinto shares for passive income?

A leading analyst provides his outlook for Rio Tinto shares and dividends.

Read more »

Woman with her fingers crossed and eyes shut.
Broker Notes

4 ASX shares upgraded by brokers this week

Brokers have new confidence in TPG Telecom, Deep Yellow, and other stocks this week.

Read more »

Three adorable children sit side by side at a table wearing upturned colanders on their heads fixed with shining light bulbs as they smile at the camera.
Broker Notes

Buy, hold, sell: Nick Scali, Nyrada, Wesfarmers shares

Experts reveal their ratings on three ASX shares in the retail and biotech segments. 

Read more »